SYRE
Spyre Therapeutics, Inc.$68.89-3.01 (-4.19%)Prev Close$71.90·MCap$4.21B·P/E—·Vol773.6K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
8
$4.24M
◆
Net Activity
Net Seller
$4.24M
●
Active Insiders
3
last 12 mo
Over the past 12 months, insider activity at Spyre Therapeutics, Inc. (SYRE) has been exclusively selling, with 0 insider purchases totaling $0.00 and 8 insider sales totaling $4.24M. The most recent insider transaction was by Burrows Scott L (officer: Chief Financial Officer), who sold $370.1K worth of shares on Apr 3, 2026. Spyre Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $4.21B.
SYRE Insider Trading Activity
SYRE Insider Buying Activity
The following table shows recent insider purchases of Spyre Therapeutics, Inc. (SYRE) stock reported via SEC Form 4 filings.
SYRE Insider Selling Activity
The following table shows recent insider sales of Spyre Therapeutics, Inc. (SYRE) stock reported via SEC Form 4 filings.